Compositions and methods for enhanced drug delivery

Details Compositions and methods for enhanced drug delivery Compositions and methods for enhanced drug delivery

1995-05-24

1997-03-04

Levy, Neil S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

604 20, 514 1, 514 2, 514 26, 514183, 514169, 514553, 514556, A61K 970, A61K 3100

Patent

active

056076916

ABSTRACT:
The present invention relates to methods of delivering pharmaceutical agents across membranes, including the skin layer or mucosal membranes of a patient. A pharmaceutical agent is covalently bonded to a chemical modifier, via a physiologically cleavable bond, such that the membrane transport and delivery of the agent is enhanced.

REFERENCES:
patent: 3472931 (1969-10-01), Stoughton
patent: 4006218 (1977-02-01), Sipos
patent: 4144328 (1979-03-01), Vainshtein et al.
patent: 4195172 (1980-03-01), Falkowski et al.
patent: 4294958 (1981-10-01), Falkowski et al.
patent: 4427660 (1984-01-01), Schiffman et al.
patent: 4454065 (1984-06-01), Gilvarg et al.
patent: 4588580 (1986-05-01), Gale et al.
patent: 4645502 (1987-02-01), Gale et al.
patent: 4727151 (1988-02-01), Bodor
patent: 4788062 (1988-11-01), Gale et al.
patent: 4816258 (1989-03-01), Nedberg et al.
patent: 4846826 (1989-07-01), Shaw et al.
patent: 4900555 (1990-02-01), Cheng et al.
patent: 4904475 (1990-02-01), Gale et al.
patent: 4908027 (1990-03-01), Enscore et al.
patent: 4927408 (1990-05-01), Haak et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 4978337 (1990-12-01), Theeuwes
patent: 5011686 (1991-04-01), Pang
patent: 5013653 (1991-05-01), Huston et al.
patent: 5028435 (1991-07-01), Katz et al.
patent: 5053227 (1991-10-01), Chiang et al.
patent: 5149539 (1992-09-01), Ledger et al.
patent: 5219564 (1993-06-01), Zalipsky et al.
patent: 5223261 (1993-06-01), Nelson et al.
patent: 5246967 (1993-09-01), Zezza
patent: 5270472 (1993-12-01), Taglialatela et al.
Bodor, et al. Int. J. Pharm, 35(1-2) 47-59 1987 Improved Delivery Through Biological Membranes.
Pratt et al., 1990, Principles of drug action: The basis of pharmacology 203-227 Principles of drug action: The basis of pharmacology.
Russell-Jones et al., 1988, Proceed Intern. Symp. Control. Rel. Bioact. Mater. 85: 142-143 Vitamin B12: A novel carrier for orally presented antigens.
Bodde et al., 1989, Biochemical Society 17 (3): 197-199 Transdermal peptide delivery.
Sanderson et al., 1989, J. of Pharm. Sci. 78 (5): 361-364. Iontophoretic delivery of nonpeptide drugs: Formulation optimization for maximum skin permeability.
Harris, Physical Medicine Library vol. IV, Therapeutic electricity and ultraviolet radiation, pp. 146-149.
Foder et al., 1991, Science 251: 767-773 Light-Directed, spatially addressable parallel chemical synthesis.
Bioworld 29 Jan 92, 3 (20): p. 1 FDA approves Elan's nicotine patch.
Chien et al., 1989, J. Pharm. Sci. 78 (5): 376-383 Direct current iontophoretic transdermal delivery of peptide and protein drugs.
Srinivasan et al., 1989, J. of Pharm. Sci. 78(5): 370-375 Transdermal iontophoretic drug delivery : Mechanistic analysis and application to polypeptide delivery.
West, Textbook of Biochemistry, Ch. 6: 169-170 Lipids.
Chien et al., 5 May 1989, J. Pharm. Sci. 78 (5): 353-354 Iontophoretic (transdermal) delivery of drugs: Overview of historical development.
Fix et al., 1986, The American Physiological Society: G332-G340 Acylccarnitines: drug absorption-enhancing agents in the gastrointestinal tract.
Banga et al., 1988, J. Controlled Release 7: 1-24 Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applications.
Bernstein, 92, Bioworld 3 (105): p.1 Patch developers extinguish suits.
Behl et al., 1989, J. of Pharm. Sci. 78 (5): 355-360 Iontophoretic drug delivery: Effects of physicochemical factors on the skin uptake of nonpeptide drugs.
Benet et al., Pharmacokinetics: The dynamics of drug absorption, Distributuion, and elimination. Ch. 1: 3-10 Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination.
Phipps et al., 1989, J. of Pharm. Sci. 78 (5): 365-369 Iontophoretic delivery of model inorganic and drug ions.
Ames et al., Feb. 1973, Proc. Natl. Acad. Sci. USA 70(2): 456-458 Illicit Transport: The Oligopeptide Permease.
Bodor et al., 18 Sep. 1992, Science 257: 1698-1700 A strategy for delivering peptides into the central nervous system by sequential metabolism.
Jacobson et al., 1986, Mol. Pharmacol. 29: 126-133 A fuctionalized congener approach to adenosine receptor antogonists: Amino Acid conjugates of 1,3-Dipropylxanthine.
Jacobson et al., 1987, J. Med. Chem. 30: 1529-1532 Binary Drugs: Conjugates of purines and a peptide that binds to both adenosine and substance P receptors.

Affiliated with

Also associated with

Rating

Compositions and methods for enhanced drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for enhanced drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhanced drug delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2144383